Search - tctmd.com

Displaying 201 - 220 of 309

Sort: Relevancy | Date

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Presenter: Jos? Mar?a Cubero G?mez

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

News Conference News TCT 2014

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

September 16, 2014

News Conference News TCT 2014

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

September 16, 2014

Presentation TCT 2014

Consensus and Take-home Messages

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White, Eun-Seok Shin

September 15, 2014

Presentation TCT 2014

Case #2: Complex Triple Vessel Disease with ACS and Diabetes

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White

September 15, 2014

Presentation TCT 2014

How Did I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White, Jang-Whan Bae

September 15, 2014

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White, Sufia Rahman

September 15, 2014

Presentation TCT 2014

Case #1: Pulmonary Edema and NSTEMI Due to Left Main Stenosis with Diabetes and Kidney Disease

Presenter: Taehoon Ahn, Afzalur Rahman, Harvey D. White, Jang-Whan Bae

September 15, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Upendra Kaul

September 14, 2014

News Conference News TCT 2014

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

Presentation TCT 2014

Case Presentation #1: The Diabetic Patient Needing Revascularization

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Adolfo G López Campanher

September 13, 2014

Advertisement

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)_

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Experts Consider Role of Statins in Prevention of Contrast-Induced Nephropathy

EXCITE ISR: Laser Atherectomy Superior to Angioplasty Alone for Femoropopliteal In-Stent Restenosis

Consensus and Take-home Messages

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #2: Complex Triple Vessel Disease with ACS and Diabetes

How Did I Treat This Patient?

How Would I Treat This Patient?

Case #1: Pulmonary Edema and NSTEMI Due to Left Main Stenosis with Diabetes and Kidney Disease

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

Keynote Address Focuses on Newer DES, Problematic Subgroups

COMBO Stent Achieves Neointimal Regression at 24 Months

Is There a Preferential DES Type in Patients with Diabetes? Current Data and TUXEDO Trial Design

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB EXTEND: BVS Safe Out to 3 Years

Case Presentation #1: The Diabetic Patient Needing Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content